HBV与HCV融合基因免疫的抗肿瘤作用研究

目的 :观察基因疫苗SpcDNA3.1、CpcDNA3.1及融合基因疫苗CSpcDNA3.1诱导BALB c小鼠 (H 2 d)的特异性细胞免疫应答及其对稳定表达HBsAg和HCcAg的小鼠肥大细胞瘤P815细胞 (H 2 d)接种动物后成瘤性的影响。方法 :3种重组质粒SpcDNA3.1、CpcDNA3 1和CSpcDNA3 1分别肌注免疫小鼠 ,3w后背部皮下接种质粒CSpcDNA3 1转染的P815细胞 ,观察小鼠成瘤和存活时间。LDH法检测免疫小鼠的脾淋巴细胞CTL活性。结果 :融合质粒CSpcDNA3 1可显著抑制肿瘤出现和生长 ,小鼠生存时间明显延长 ,生存率提高 ,CSpcDNA3 1免疫的小鼠脾淋巴细胞体外对转染的P815肿瘤细胞有明显的杀伤作用。结论 :融合基因疫苗CSpcDNA3 1免疫的小鼠能诱发特异性抗肿瘤细胞免疫。

Study on antitumor effect by gene immunization of the chimeric HBV and HCV

Objective:To observe the specific cellular immune response and the protection against P815 mastovytoma cells(H 2 d) stable expressing HBV surface antigen and HCV core antigen after the immunized mice(H 2 d) with plasmids SpcDNA3.1,CpcDNA3.1 and chimeric plasmid CSpcDNA3.1.Methods:After subcutaneous immunization with the three plasmids SpcDNA3.1,CpcDNA3.1 and CSpcDNA3.1 respecitively 3 w,the mice were inoculated with the transfected P815 tumor cells.The tumors size and the survival rate were measured.CTL assay was detected with LDH methods.Results:The chimeric plasmid CSpcDNA3.1 could inhibit the tumor growth,prolong the survival period and improve the survivial rate evidently.The splencytes from immunized mice showed strong CTL activity to CSpcDNA3.1 transfected P815 tumor cells.Conclusion:It was suggestd that specific antitumor cellular immunity could be induced by immunization with the chimeric plasmid CSpcDNA3.1 that contain chimeric HBV and HCV gene.